ASX Stock

At Trader Dealer we understand the importance of information. You can use our handy company information finder to get key fundamental data about any company listed on the ASX.

Simply enter the stock code or the name of the company you are interested in for ASX share price information, company size, research analyst forecast, share and financial ratios, as well as a business and financial summary.

Don’t know the ASX code of the stock you want? Just click on the letter below for a full alphabetical listing.


Enter ASX Stock Code

Bookmark Page !



View all Companies by Letters

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 


 
 

Bionomics Limited
Industry Group: Biotechnology / Medical Research - Biotechnology

Trade Online with Trader Dealer

Sorry, No Chart Available.

Business Summary
Bionomics Limited (Bionomics) is a productive drug discovery and development engine focused on new treatments for cancer and serious disorders of the central nervous system (CNS). Bionomics is engaged in undertaking research and development utilising Bionomics’ technology platforms with the aim of identifying and developing therapies to treat cancer and conditions of the CNS, including anxiety, Multiple Sclerosis and epilepsy, and commercialise intellectual property assets. The Company operates in three segments: drug discovery, drug development and contract services. Drug discovery is the creation and ongoing testing of compounds to determine the best compound that matches the product profile. Drug development is defined as the ongoing testing, including clinical trials of the best compound with a view to commercialization of the compound. Contract services is the provision of scientific services on a fee for service basis to both external and internal customers.

Financial Summary
BRIEF: For the fiscal year ended 30 June 2011, Bionomics Limited's revenues increased 7% to A$4.1M. Net loss increased 14% to A$9.4M. Revenues reflect a substantial increase in income from Drug discovery segment and significant raise in income from Contract services segment. Net loss reflects by a substantial increase in administrative expense and significant raise in research & development expense.

Business Address


31 Dalgleish Street
ADELAIDE, SA 5031
Phone: 61-8-83546100
Fax: 61-8-83546199
http://www.bionomics.com.au/

ASX Share Price Information
Current Price 0.470
Current Price Date 22/02/2012
52 Week Hi/Low 0.77 - 0.36
Avg Volume Last ten Days 0.16
ASX Company Sizing
Market Cap 162.13
Revenues 148.91
EBITDA -8.86
Net Income -9.36
Number of Employees -
Enterprise Value 148.91
Research Analyst Forecast
Consensus Recommendation Outperform
Target Price 1.43000
LT Growth Rate -
Projected P/E -18.43137
Sales 5.95000
EPS -0.02550
Profit -9.76900
DPS 0.00000
Share Ratios
EPS -0.02910
RPS 0.01286
BV per Share 0.08325
Cash per Share 0.04656
Cashflow per Share -0.02616
Cashflow per Share 0.00000
Financial Ratios
Gross Margin 100.00000
ROE -34.54810
Price/Sales 39.19551
P/E -
P/Book 5.64559